iRhythm, ZIO Service, arrhythmia detection, wearable, Holter monitors

iRhythm Technologies Inc. announced the study, “Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients,” was published in the Journal of Health Economics and Outcomes Research. The study assessed the costs incurred in the diagnosis, additional monitoring and following clinical events after the initial use of the Holter monitor among Medicare patients with arrhythmia.

Cerner Corp. and development partner Mortara Instrument have joined together to introduce CareAware Waveform Management. The system displays waveforms and other physiological data from patient monitoring systems and integrates them into the electronic health record (EHR).

Radiation dose monitoring software analytics offered by Sectra.
Sectra radiation dose monitoring software showing comparison of dose between several scanners.
Dosemonitor CTDIvol dose management for CT scanners.

Cardiac imaging accounts for about one-third of the source of X-ray radiation dose for all medical imaging. Expanding use of computed tomography (CT) for cardiac evaluations, use of nuclear imaging for myocardial perfusion exams and more complex transcatheter procedures in the cath lab have all increased patient exposure in recent years. 

The spirit of collaboration to improve health with information technology came to Cleveland, Ohio, when the Integrating the Healthcare Enterprise (IHE) North American Connectathon 2015 opened in January 2015. Almost 100 organizations and 555 engineers attended this annual testing event.

Physicians who use the clinical reference tool, DynaMed from EBSCO Health, can now access the valuable, evidence-based content anywhere with the new DynaMedmobile app. The new app has been redesigned to make it easier and faster for physicians to find answers to clinical questions.

Adam Greenbaum, M.D., and William O'Neill, M.D., perform a TAVR procedure in a hybrid cath lab at Henry Ford Hospital in Detroit. Structural heart

Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology is viewed as cutting edge not only with clinicians, but also among the general public. This can be leveraged to promote the hospital as a cutting-edge facility and help attract new patients. However, creating these programs requires long-term financial, professional and equipment commitments, which may not be right for all hospitals. There are also concerns that a proliferation of TAVR centers may make programs less profitable and reduce the proficiency of any one center as patient volumes decrease if patients are spread between many competing hospitals.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now